Informationen:
Fehler:
ID
15847
Beschreibung
Effect of the Angiotensin II Receptor Antagonist Irbesartan on Biochemical and Functional Markers of Endothelial Dysfunction in Patients With Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT00529750
Link
https://clinicaltrials.gov/show/NCT00529750
Stichworte
Versionen (1)
- 15.06.16 15.06.16 -
Hochgeladen am
15. Juni 2016
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Hypertension NCT00529750
Eligibility Hypertension NCT00529750
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Hypertension NCT00529750
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
hypertension
Item
hypertension grade 1 or 2
boolean
C0020538 (UMLS CUI [1])
metabolic syndrome
Item
with at least two of the following criteria for the diagnosis of metabolic syndrome:
boolean
C2229034 (UMLS CUI [1])
body mass index
Item
body mass index > or = 25 kg/m2 and waist circumference > or = 100 cm.
boolean
C1305855 (UMLS CUI [1])
C0455829 (UMLS CUI [2])
C0455829 (UMLS CUI [2])
dyslipidemia
Item
dyslipidemia (triglycerides fasting serum levels > or = 200 mg/dl or hdl serum levels < or = 40 mg/dl)
boolean
C0242339 (UMLS CUI [1])
fasting serum glucose
Item
fasting serum glucose > or = 110 mg/dl but < 126 mg/dl
boolean
C0583334 (UMLS CUI [1])
hypersensitivity to irbesartan
Item
known hypersensitivity to irbesartan
boolean
C0020517 (UMLS CUI [1,1])
C0288171 (UMLS CUI [1,2])
C0288171 (UMLS CUI [1,2])
hypertension grade 3
Item
hypertension grade 3
boolean
C0020538 (UMLS CUI [1,1])
C0450094 (UMLS CUI [1,2])
C0450094 (UMLS CUI [1,2])
clinical vascular events
Item
history of clinical vascular events such as tias, stroke, peripheral arterial disease
boolean
C0007787 (UMLS CUI [1])
C0038454 (UMLS CUI [2])
C1704436 (UMLS CUI [3])
C0038454 (UMLS CUI [2])
C1704436 (UMLS CUI [3])
coronary artery disease
Item
coronary artery disease
boolean
C1956346 (UMLS CUI [1])
renal insufficiency
Item
renal insufficiency (creatinine serum levels > or = 1.2 mg/dl)
boolean
C0201976 (UMLS CUI [1])
heart failure
Item
presence of clinical heart failure
boolean
C0018801 (UMLS CUI [1])
asthma and copd
Item
asthma and copd
boolean
C0004096 (UMLS CUI [1])
C0024117 (UMLS CUI [2])
C0024117 (UMLS CUI [2])
valvular cardiopathy
Item
valvular cardiopathy clinically relevant
boolean
C1392010 (UMLS CUI [1])
antioxidant drugs
Item
current therapy with antioxidant drugs, statins
boolean
C0003402 (UMLS CUI [1])
C0360714 (UMLS CUI [2])
C0360714 (UMLS CUI [2])
aiira
Item
therapy with aiira for at least 3 months during the last semester
boolean
C0521942 (UMLS CUI [1])
acute illness or major trauma
Item
presence of any acute illness or major trauma in the last 8 weeks
boolean
C0009488 (UMLS CUI [1])
chronic inflammatory disease
Item
history of a chronic inflammatory disease such as rheumatoid arthritis, immune disorders or connective tissue disease.
boolean
C1290886 (UMLS CUI [1])
C0003873 (UMLS CUI [2])
C0004364 (UMLS CUI [3])
C0009782 (UMLS CUI [4])
C0003873 (UMLS CUI [2])
C0004364 (UMLS CUI [3])
C0009782 (UMLS CUI [4])
exclusion criteria
Item
the above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
boolean